Literature DB >> 10833098

Impact of bile acid malabsorption on steatorrhoea and symptoms in patients with chronic diarrhoea.

K A Ung1, A F Kilander, A Lindgren, H Abrahamsson.   

Abstract

OBJECTIVE: Bile acids are important for fat absorption. The relationship between bile acid malabsorption and steatorrhoea and gastrointestinal symptoms in patients with chronic diarrhoea has only been studied on a limited scale.
DESIGN: Ninety-four patients referred for chronic diarrhoea were prospectively investigated with the 75SeHCAT test, a faecal fat excretion test and registration of symptoms in addition to the standard clinical work-up.
METHODS: The correlation between the 75SeHCAT value and the faecal fat excretion was calculated for different groups of patients. Symptoms were registered in a questionnaire over a period of seven consecutive days.
RESULTS: Forty-two patients had a 75SeHCAT value < 10%. Mild steatorrhoea was common in patients with non-organic bile acid malabsorption (50%) and in patients with functional diarrhoea (38%). There was no correlation between low 75SeHCAT values and steatorrhoea, although some patients with severe organic disease had a concomitant malabsorption of fat and of bile acids. In coeliac disease, severe steatorrhoea was common even in patients with high 75SeHCAT values. Patients with bile acid malabsorption had more frequent (P < 0.008) and looser (P= 0.0021) stools compared with patients with functional diarrhoea. There was no difference in abdominal pain, distension or flatulence.
CONCLUSION: Mild steatorrhoea is common in both non-organic bile acid malabsorption and functional diarrhoea. The 75SeHCAT value cannot predict the risk of steatorrhoea. The high prevalence of bile acid malabsorption in patients with chronic diarrhoea and the absence of specific symptoms, except frequent and more liquid stools, indicates that the 75SeHCAT test should be performed early in the investigation of these patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10833098     DOI: 10.1097/00042737-200012050-00011

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  8 in total

1.  Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea.

Authors:  Banny S Wong; Michael Camilleri; Paula Carlson; Sanna McKinzie; Irene Busciglio; Olga Bondar; Roy B Dyer; Jesse Lamsam; Alan R Zinsmeister
Journal:  Clin Gastroenterol Hepatol       Date:  2012-05-18       Impact factor: 11.382

2.  Managing bile acid diarrhoea.

Authors:  Julian R F Walters; Sanjeev S Pattni
Journal:  Therap Adv Gastroenterol       Date:  2010-11       Impact factor: 4.409

3.  Postinfectious Irritable Bowel Syndrome.

Authors:  Kok-Ann Gwee
Journal:  Curr Treat Options Gastroenterol       Date:  2001-08

Review 4.  Bile acid malabsorption in chronic diarrhea: pathophysiology and treatment.

Authors:  Alan N Barkun; Jonathan Love; Michael Gould; Henryk Pluta; Hillary Steinhart
Journal:  Can J Gastroenterol       Date:  2013-11       Impact factor: 3.522

5.  Phytosterol and phytostanol esters are effectively hydrolysed in the gut and do not affect fat digestion in ileostomy subjects.

Authors:  L Normén; L Ellegård; H-G Janssen; H Steenbergen; E Trautwein; H Andersson
Journal:  Eur J Nutr       Date:  2006-03-21       Impact factor: 5.614

6.  The bile acid turnover rate assessed with the (75)SeHCAT test is stable in chronic diarrhoea but slightly decreased in healthy subjects after a long period of time.

Authors:  Antal Bajor; Anders Kilander; Henrik Sjövall; Mats Rudling; Kjell-Arne Ung
Journal:  Dig Dis Sci       Date:  2008-04-25       Impact factor: 3.199

7.  Vitamin D and vitamin B12 deficiencies are common in patients with midgut carcinoid (SI-NET).

Authors:  A Lind; B Wängberg; L Ellegård
Journal:  Eur J Clin Nutr       Date:  2016-03-30       Impact factor: 4.016

8.  Canadian Association of Gastroenterology Clinical Practice Guideline on the Management of Bile Acid Diarrhea.

Authors:  Daniel C Sadowski; Michael Camilleri; William D Chey; Grigorios I Leontiadis; John K Marshall; Eldon A Shaffer; Frances Tse; Julian R F Walters
Journal:  J Can Assoc Gastroenterol       Date:  2019-12-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.